Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1) - Concepedia

Concepedia

Publication | Closed Access

Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1)

17

Citations

19

References

2002

Year

Jeroen D. van Bergeijk, J. H. P. Wilson, Ole Haagen Nielsen, Christian von Tirpitz, Anna-Lusa Karvonen, I. Lygren, A Rádler, Helge L. Waldum, Chris J. Mulder, S. Friis,

European Journal of Gastroenterology & Hepatology

Abstract

Subcutaneous administration of octreotide 500 microg thrice daily is not of additional benefit as adjuvant therapy to high dose corticosteroids in severe ulcerative colitis.

References

	Year	Citations

Page 1